Consumers Who Bought Elimidrol ‘Opiate Withdrawal’ Product to Receive Refunds
Elimidrol was deceptively marketed as a way to alleviate opiate withdrawal symptoms and increase a user's likelihood of overcoming addiction
The Federal Trade Commission (FTC) is mailing 5,379 refund checks totaling more than $210,000 to people who bought Elimidrol, a product marketed by Sunrise Nutraceuticals, LLC, as an effective treatment for opiate addiction withdrawal.
The average refund amount is $39.
According to the FTC's November 2015 complaint, Sunrise deceptively claimed that Elimidrol—a powdered drink mix consisting of herbs and other compounds—could alleviate opiate withdrawal symptoms and increase a user's likelihood of overcoming opiate addiction.
Under the court order settling the FTC's charges, Sunrise was barred from making such unsubstantiated health and efficacy claims, and agreed to pay $235,000 in redress for consumer refunds.
Rust Consulting, Inc., the refund administrator in this case, has begun mailing the refund checks. The checks must be cashed by November 27, 2017 or they will become void.
Beware of scammers
The FTC reminds check recipients that it never requires consumers to pay money or provide sensitive personal information to cash refund checks. If anyone says otherwise or requests such information, it's more than likely scam and should be reported to the FTC immediately.
For more information about this case or the FTC's refund process, consumers can call (866) 880-0103.